Randomised trial, 2026
Strain LB42 was assessed from preclinical safety through to gut microbiota and immune measures, reporting effects on microbial composition and immune markers.
Food and Chemical ToxicologyLactobacillus acidophilus is the lead active here, studied most for comfort after dairy. In the 200 mg Mood Probiotic Blend with 18 others, listed third. Ashwagandha (root) is the most studied active here, with 21 human studies behind it, each one cited. Who it fits: for everyone, adults.

The panel on the left is the one we evaluated, line by line.
All 26 actives checked against the clinical evidence: dose, form, and what the research actually shows.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Backed by human trials".
The verdict is public and comes from the formula alone. A formula that does not clear the bar gets nothing.
Read by the engine against 835,013 data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
Cross-checked against 56 documented interactions for these actives.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
Randomised trial, 2026
Strain LB42 was assessed from preclinical safety through to gut microbiota and immune measures, reporting effects on microbial composition and immune markers.
Food and Chemical ToxicologySystematic review, 2022
Across randomised trials, resistant starch was generally well tolerated at the doses studied, and increases in short-chain fatty acid production were seen in some trials but not all.
The American journal of clinical nutritionRandomised trial, 2026
Bifidobacterium supplementation was associated with greater gut microbiota stability and better self-reported well-being over the study period.
Frontiers in NutritionSystematic review, 2026
The review surveys neurobiological effects of microbial interventions in psychiatry and finds the evidence base heterogeneous and preliminary.
Frontiers in PsychiatryRandomised trial, 2025
A randomised controlled trial of a probiotic product containing L. helveticus. The strain was given inside a combination, so no result can be attributed to it alone.
International Journal of Molecular SciencesRandomised trial, 2026
A synbiotic combining strains including this species with fibre was compared against control for abdominal visceral fat measures and gut microbiota in adults carrying excess body weight. The intervention was a multi-component synbiotic, so nothing is attributable to one strain.
Clinical NutritionMeta-analysis, 2020
Pooling four randomized trials in 142 athletes and healthy adults, ashwagandha raised maximal oxygen uptake (VO2max) by about 3.0 mL/kg/min compared with placebo.
NutrientsMeta-analysis, 2017
Across randomised trials, blueberry supplementation did not produce a detectable change in systolic or diastolic blood pressure.
The paperRandomised trial, 2026
Infants given a specific probiotic strain had fewer caregiver-reported bouts of skin irritation and breathing or digestive symptoms than infants without it, specific to that strain and dose.
QJMRandomised trial, 2014
Preterm neonates given Bifidobacterium breve M-16V had higher faecal bifidobacteria counts than those given placebo.
PloS oneRandomised trial, 2016
In growth restricted very preterm infants, M-16V supplementation raised faecal bifidobacteria counts compared with placebo.
The journal of maternal-fetal & neonatal mediRandomised trial, 2026
A randomised controlled trial reported that Bifidobacterium longum subsp. infantis B8762 altered infant gut microbial and metabolic profiles.
Microbial pathogenesisSystematic review, 2026
A review of early-life probiotics found effects on respiratory infection measures varied by strain, so results can't be generalized across strains.
NutrientsSystematic review, 2025
Pooled data support vertical mother-to-infant transmission of Bifidobacterium strains in early life, with transmission proportions varying by species and delivery mode.
NPJ Biofilms and MicrobiomesPopulation figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.
In a double blind trial in 16 recreational runners, 4 weeks of daily Lactobacillus plantarum PS128 capsules taken before a half marathon preserved knee extensor torque and electromyographic measures of muscle function across the 96 hours after the race compared with placebo.
In a double blind, randomized, placebo controlled trial in adults aged 20 to 40 with above-normal body weight, daily Lactobacillus plantarum GKM3 at 1 g per day for 4 weeks increased bowel movement frequency compared with placebo.
In a randomised preliminary trial, sixteen healthy national-level cross-country skiers took Bifidobacterium lactis BL-99 daily for 8 weeks. Over the supplementation period, gut abundance of Bifidobacterium animalis rose about forty-fold and blood triglyceride levels shifted.
In a 60 day randomised, double-blind, placebo-controlled trial, 60 stressed healthy adults took 240 mg of a standardised ashwagandha extract (Shoden) once daily or placebo. The ashwagandha arm showed a larger fall in Hamilton Anxiety Rating Scale scores (p = .040) and in morning cortisol (p < .001) than placebo, with the DASS-21 change near-significant (p = .096). A separate 8 week randomised, double-blind, placebo-controlled dose-ranging trial enrolled 131 adults with self-reported high stress and analysed 98, measuring reduced Perceived Stress Scale scores at 125, 250 and 500 mg per day of an aqueous root and leaf extract. Two trials on two different extracts, both landing in the same eight to nine week band.
In a small preliminary study, nine older adults with early age-related memory changes drank wild blueberry juice daily for 12 weeks and improved on paired-associate learning and word-list recall, with scores compared against a demographically matched group given a berry placebo drink. One study of nine people, juice rather than a capsule.
Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.
12 ingredients, from each one's own page.
Before digestion settles into a steadier pattern. Some gut rumbling in the first few days is the earliest sign anything is shifting.
Membrane fatty acids turn over across four to twelve weeks, so any change reads out on a red cell fatty acid panel rather than as a sensation.
Digestive changes usually appear within one to two weeks. A steadier bowel pattern generally settles around week three or four.
Before digestion feels steadier. It works while you're taking it, since the organism passes through rather than settling in.
Is the window the stress and mood trials ran on. Digestive changes tend to arrive in the same stretch.
Digestive changes usually turn up in the first one to two weeks. The steadier pattern in bowel habit tends to settle around week three or four.
Probiotic changes in digestion usually show over one to four weeks of daily use rather than on the first day.
Give it two to four weeks of daily intake. The strains show up in stool within days, but the digestive changes people report land in that two to four week window.
Easier digestion of a dairy meal happens during that meal, because the enzyme works there. Anything broader is a slow shift measured over weeks.
Trials ran twelve weeks before abdominal measurements moved, so this is tracked with a tape measure across months rather than noticed in a week.
Give it three to four weeks. Oral studies read gum bleeding scores and plaque bacteria counts at four to eight weeks, so the change is measured before it is obvious.
Give it one to four weeks of daily use. Stool regularity and less day-to-day bloating are usually the first things people notice.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
It is a capsule, so the amount per serving is fixed and travels without measuring.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.